← Leaderboards
Michelle Louise James
Stanford University
$4,919,512
Attributed
$5,425,219
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,425,219 · 8
By mechanism
R01$3,265,340 · 3
R21$2,159,879 · 5
Top collaborators
- Katrin I Andreasson2 shared
- Frank M Longo2 shared
- Tarik F Massoud2 shared
Most similar at Stanford University
Same institution · by research overlap
- Robert S Negrin$29,816,136
- Dean W Felsher$32,145,773
- Sylvia Katina Plevritis$44,733,712
- Ronald Levy$27,846,042
- Prasanna Jagannathan$10,796,952
Others in their field
Top investigators on “Monitor”
- Jeffrey P Krischer · University Of South Florida$631,818,376
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$476,087,269
- Bambra Strokes · Ppd Development Lp$461,655,950
- David Heimbrook · Leidos Biomedical Research, Inc.$367,240,481
- Lawrence Corey · Fred Hutchinson Cancer Center$302,301,802
Research focus
MonitorPositron-Emission TomographyTracerImageCellsMouse ModelAreaDetectionIn VivoBrainAffectSignal TransductionResponseImmuneImaging AgentClinical TrialsClinical TranslationFutureTreatment ResponseRadiotracerIn VitroCostAffinityClinically Relevant
Grant awards (16)
Developing clinically relevant PET tracers to image T cell activation for improved cancer immunotherapy monitoring$535,187
R01 · FY2025 · CA · contact PI
In vivo tracking of innate immune activation and therapeutic response in MS mouse models using [18F]OP-801$424,234
R21 · FY2025 · NS · contact PI
Developing clinically relevant PET tracers to image T cell activation for improved cancer immunotherapy monitoring$525,196
R01 · FY2024 · CA · contact PI
Imaging B cells in the brain and beyond: developing an immuno-PET toolbox to improve understanding and treatment of multiple sclerosis$359,935
R01 · FY2024 · NS · contact PI
Imaging B cells in the brain and beyond: developing an immuno-PET toolbox to improve understanding and treatment of multiple sclerosis$371,053
R01 · FY2023 · NS · contact PI
A new P2Y12R PET radioligand for measuring microglial function in Alzheimer's disease$436,144
R21 · FY2022 · AG · contact PI
Imaging B cells in the brain and beyond: developing an immuno-PET toolbox to improve understanding and treatment of multiple sclerosis$371,040
R01 · FY2022 · NS · contact PI
Imaging inflammation in the whole body and brain of ME/CFS patients$235,253
R21 · FY2022 · NS · contact PI
Imaging B cells in the brain and beyond: developing an immuno-PET toolbox to improve understanding and treatment of multiple sclerosis$370,812
R01 · FY2021 · NS · contact PI
Imaging inflammation in the whole body and brain of ME/CFS patients$196,398
R21 · FY2021 · NS · contact PI
Imaging B cells in the brain and beyond: developing an immuno-PET toolbox to improve understanding and treatment of multiple sclerosis$370,595
R01 · FY2020 · NS · contact PI
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease$361,522
R01 · FY2020 · CA · contact PI
Tracking the invaders in multiple sclerosis: Highly specific TREM1-targeted PET imaging of toxic infiltrating myeloid cells and early treatment response.$234,910
R21 · FY2019 · NS · contact PI
Tracking the invaders in multiple sclerosis: Highly specific TREM1-targeted PET imaging of toxic infiltrating myeloid cells and early treatment response.$195,781
R21 · FY2018 · NS · contact PI
New PET imaging agent for monitoring treatment response in Alzheimer's disease$198,927
R21 · FY2016 · AG · contact PI
New PET imaging agent for monitoring treatment response in Alzheimer's disease$238,232
R21 · FY2015 · AG · contact PI